Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Bayer’s Xarelto wins another NICE recommendation

Deemed cost-effective use of NHS resources to prevent blood clots following a heart attack

- PMLiVE

Roche outlines $3bn expansion for its Basel site

Decade-long programme will see the Swiss pharma company boost its presence in its home city

- PMLiVE

Emma Eatwell returns to Hanover

Will lead its Brussels healthcare business

- PMLiVE

Are you getting what you’re worth?

PMLiVE salary survey opens to gauge the state of play with industry pay

- PMLiVE

The future of pharmacy in the UK

Community pharmacy dispensing is being challenged on three fronts

- PMLiVE

J&J to produce one million doses of Ebola vaccine

Commits $200m to speed up research

- PMLiVE

Amgen should split up, says investor

Hedge fund manager Daniel Loeb criticises big biotech firm's 'bloated cost structure'

- PMLiVE

Amgen should split up, says investor

Hedge fund manager Daniel Loeb criticises big biotech firm's 'bloated cost structure'

- PMLiVE

Takeda’s obesity drug Contrave launches in US

Clears cardiovascular safety hurdle to be third new weight-loss drug in recent months

- PMLiVE

NICE backs GSK’s Tafinlar for skin cancer

Joins Yervoy and Zelboraf as a recommended melanoma treatment

- PMLiVE

‘Millennials’ turning to self-diagnosis, says report

And mental health is an increasing priority

- PMLiVE

Amgen appoints R Sanders Williams to board of directors

He is president of Gladstone Institutes

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links